Sustained ERK-2 activation in rat glomerular mesangial cells: Differential regulation by protein phosphatases

American Journal of Physiology

Volumn 271, Issue 2 PART 2, 1996, Pages

  Schramek, Herbert ^a   Schumacher, Michael ^a   Pfaller, Walter ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Endothelin; Epidermal growth factor; Mitogen activated protein kinase; Platelet derived growth factor

Indexed keywords

PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; ENZYME REGULATION; GLOMERULOPATHY; MESANGIUM; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RAT; SIGNAL TRANSDUCTION;

ANIMALS; CA(2+)-CALMODULIN DEPENDENT PROTEIN KINASE; DACTINOMYCIN; DRUG COMBINATIONS; ENDOTHELIN-1; ENZYME ACTIVATION; ENZYME INHIBITORS; EPIDERMAL GROWTH FACTOR; GLOMERULAR MESANGIUM; MALE; MAP KINASE KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; PLATELET-DERIVED GROWTH FACTOR; PROTEIN SYNTHESIS INHIBITORS; PROTEIN-SERINE-THREONINE KINASES; PROTEIN-TYROSINE KINASES; RATS; RATS, SPRAGUE-DAWLEY; RECOMBINANT PROTEINS; TIME FACTORS; VANADATES;

EID: 0029736659     PISSN: 00029513     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajprenal.1996.271.2.f423     Document Type: Article

References (42)

1. Alessi, D. R., C. Smythe, and S. M. Key. The human CL100 gene encodes a Tyr/Thr-protein phosphatase which potently and specifically inactivates MAP kinase and suppresses its activation by oncogenic ras in Xenopus oocyte extracts. Oncogens 8: 2015-2020,1993.
2. Bokemeyer, D., A. Sorokin, M. Yan, N. G. Ahn, D. J. Templeton, and M. J. Dünn. Induction of mitogen-activated protein kinase phosphatase 1 by the stress-activated protein kinase signaling pathway but not by extracellular signal-regulated kinase in fibroblasts. J. Biol. Chem. 271: 639-642,1996.
3. Brunei, A., G. Pages, and J. Pouysségur. Constitutively active mutants of MAP kinase kinase (MEK1) induce growth factor-relaxation and oncogenieity when expressed in fibroblasts. Oncogens 9: 3379-3387,1994.
4. Charles, C. H., A. S. Abler, and L. F. Lau. cDNA sequence of a growth factor-inducible immediate early gene and characterization of its encoded protein. Oncogene 7:187-190,1992.
5. Cobb, M. H., and E. J. Goldsmith. How MAP kinases are regulated. J. Biol. Chem. 270:14843-14846,1995.
6. Cohen, P., C. F. B. Holmes, and Y. Tsukitani. Okadaic acid: a new probe for the study of cellular regulation. Trends Biochem. Sei. 15: 98-102,1990.
7. Cowley, S., H. Paterson, P. Kemp, and C. J. Marshall. Activation of MAP kinase is necessary and sufficient for PC 12 differentiation and for transformation of NIH 3T3 cells. Cell 77: 841-852,1994.
8. Crews, C. M., and B. L. Erikson. Extracellular signals and reversible protein phosphorylation: what to Mek of it all. Cell 74: 215-217,1993.
9. Duff, J. L., B. P. Monia, and B. C. Berk. Mitogen-activated protein (MAP) kinase is regulated by the MAP kinase phosphatase (MKP-1) in vascular smooth muscle cells. J. Biol. Chem. 270: 7161-7166,1995.
10. Gordon, J. A. Use of vanadate as protein-phosphotyrosine phosphatase inhibitor. Methods Enzymol. 201: 477-482,1991.
11. Greene, L. A., and A. S. Tischler. Establishment of a norandregenic clonal line of rat adrenal phaeochromocytoma cells that respond to nerve growth factor. Proc. Natl. Acad. Sei. USA 73: 2424-2428,1976.
12. Heasly, L. E., and G. L. Johnson. The ß-PDGF receptor induces neuronal differentiation of PC12 cells. Mol. Biol. Cell 3: 545-553,1992.
13. Huff, K., D. End, and G. Guroff. Nerve growth factor-induced alteration in the response of PC 12 pheochromocytoma cells to epidermal growth factor. J. Cell Biol. 88:189-198,1981.
14. Hunter, T. Protein kinases and phosphatases: the yin and yang of protein phosphorylation and signaling. Cell 80:225-236,1995.
15. Huwiler, A., S. Stabel, D. Fabbro, and J. Pfeilschifter. Platelet-derived growth factor and angiotensin II stimulate the mitogen-activated protein kinase cascade in renal mesangial cells: comparison of hypertrophie and hyperplastic agonists. Biochem. J. 305: 777-784,1995.
16. Johnson, G. L., and R. R. Vaillancourt. Sequential protein kinase reactions controlling cell growth and differentiation. Curr. Opin. Cell Biol. 6: 230-238,1994.
17. Kahan, C., K. Seuwen, S. Meloche, and J. Potiyssegur. Coordinate, biphasic activation of p44 mitogen-activated protein kinase and S6 kinase by growth factors in hamster fibroblasts. Evidence for thrombin-induced signals different from phosphoinositide turnover and adenylylcyclase inhibition. J. Biol. Chem. 267:13369-13375,1992.
18. Keyse, S. M. An emerging family of dual specificity MAP kinase phosphatases. Biochim. Biophys.Acta 1265:152-160,1995.
19. Lenormand, P., C. Sardet, G. Pages, G. L'Allemain, A. Brunei, and L. Pouysségur. Growth factors induce nuclear translocation of MAP kinases (p42mapk and p44mapk) but not of their activator MAP kinase kinase (p45mapkk) in fibroblasts. J. Cell Biol. 122:1079-1088,1993.
20. Mansour, S. J., W. T. Matten, A. S. Hermann, J. M. Candia, S. Rong, K. Fukasawa, G. F. Vande Woude, and N. G. Ahn. Transformation of mammalian cells by constitutively active MAP kinase kinase. Science Wash. DC 265: 966-970,1994.
21. Marshall, C. J. Specificity of receptor tyrosine kinase signaling: transient versus sustained extracellular signal-regulated kinase activation. Cell 80:179-185,1995.
22. Meloche, S., G. Pages, and J. Pouysségur. Functional expression and growth factor activation of an epitope-tagged p44 mitogen-activated protein kinase, p44MAPK. Mol. Biol. Cell 3: 63-71,1992.
23. Meloche, S., K. Seuwen, G. Pages, and J. Pouysségur. Biphasic and synergistic activation of p44mapk (ERK1) by growth factors: correlation between late phase activation and mitogenicity. Mol. Endocrinol. 638: 845-854,1992.
24. Mené, P., M. S. Simonson, and M. J. Dunn. Physiology of the mesangial cell. Physiol. Rev. 69:1347-1424,1989.
25. Misra-Press, A., C. S. Rim, H. Yao, M. S. Roberson, and P. J. S. Stork. A novel mitogen-activated protein kinase phosphatase. Structure, expression, and regulation. J. Biol. Chem. 270: 14587-14596,1995.
26. Nguyen, T. T., J.-C. Scimeca, C. Filloux, P. Peraldi, J.-L. Carpentier, and E. van Obberghen. Co-regulation of the mitogen-activated protein kinase, extracellular signal-regulated kinase 1 and the 90 kDa ribosomal S6 kinase in PC12 cells. J. Biol. Chem. 268: 9803-9810,1993.
27. Noguchi, T., R. Metz, L. Chen, M. G. Mattei, D. Carrasco, and R. Bravo. Structure, mapping and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol. Cell. Biol. 13: 5195-5205,1993.
28. Pages, G., A. Brunei, G. L'Allemaiii, and J. Pouysségur. Constitutive mutant and putative regulatory serine phosphorylation site of mammalian MAP kinase kinase (MEK1). EMBO J. 13: 3003-3010,1994.
29. Pages, G., P. Lenormand, G. L'Allemain, J. C. Chambard, S. Meloche, and J. Pouysségur. The mitogen-activated protein kinases p42mapk and p44mapk are required for flbroblast cell proliferation. Proc. Natl. Acad. Sei. USA 90: 8319-8323,1993.
30. Rohan, P. J., P. Davis, C. A. Moskaluk, M. Kearns, H. Krutzsch, U. Siebenlist, and K. Kelly. PAC-1: a mitogen-induced nuclear protein tyrosine phosphatase. Science Wash. DC 259:1763-1766,1993.
31. Schramek, H., A. Sorokin, R. D. Watson, and M. J. Dunn. Differential long-term regulation of MEK and of p42 MAPK in rat glomerular mesangial cells. Am. J. Physiol. 270 (Cell Physiol. 39): C40-C48,1996.
32. Seger, R., and E. Krebs. The MAPK signaling cascade. FASEB J. 9: 726-735,1995.
33. Seger, R., D. Seger, A. A. Reszka, E. S. Munar, H. EldarFinkelman, G. Dobrowolska, A. M. Jensen, J. S. Campbell, E. H. Fischer, and E. G. Krebs. Overexpression of mitogenactivated protein kinase kinase (MAPKK) and its mutants in NIH 3T3 cells. J. Biol. Chem. 269: 25699-25709,1994.
34. Simonson, M. S., and M. J. Dunn. Leukotriene C4 and D4 contract rat glomerular mesangial cells. Kidney Int. 30:524-531, 1986.
35. Sun, H., C. H. Charles, L. F. Lau, and N. K. Tonks. MKP-1 (3CH134), an immediate early gene product, is a dual phosphatase that dephosphorylates MAP kinase in vivo. Cell 75: 487493,1993.
36. Traverse, S., N. Gomez, H. Paterson, C. Marshall, and P. Cohen. sustained actiovation of the mitogen-activated protein (MAP) kinase cascade may be required for differentiation of PC12 cells. Comparison of the effects of nerve growth factor and epidermal growth factor. Biochem J. 288: 351-355,1992.
37. A. J. Am. Soc. Nephrol. 5: 1074-1080,1994.
38. Wang, Y., M. S. Simonson, J. Pouysségur, and M. J. Dunn. Endothelin rapidly stimulates mitogen-activated protein kinase activity in rat mesangial cells. Biochem. J. 287: 589-594,1992.
39. Ward, Y., S. Gupta, P. Jensen, M. Wartmann, R. J. Davis, and K. Kelly. Control of MAP kinase activation by the mitogen-induced threonine/tyrosine phosphatase PAC1. Nature Land. 367: 651-654,1994.
40. Wenzel, U. O., B. Fouqueray, P. Biswas, G. Grandaliano, G. Ghosh Choudhury, and H. E. Abboud. Activation of mesangial cells by the phosphatase inhibitor vanadate. Potential implications for diabetic nephropathy. J. Clin. Invest. 95: 1244-1252,1995.
41. Zheng, C.-F., and K.-L. Guan. Properties of MEKs, the kinases that phosphorylate and activate the extracellular signalregulated kinases. J. Biol. Chem. 268: 23933-23939,1993.
42. Zheng, C.-F., and K.-L. Guan. Dephosphorylation and inactivation of the mitogen-activated protein kinase by a mitogen-induced Thr/Tyr protein phosphatase. J. Biol. Chem. 268:16116-16119,1993.